C07C 65/40
Containing singly bound oxygen-containing groups
Official title: containing singly bound oxygen-containing groups
C07C65/40 (Containing singly bound oxygen-containing groups) appears on 226 US grants and 104 published applications in this corpus.
Search patents in C07C- Granted patents
- 226
- Published applications
- 104
- Assignees
- 129
- Inventors
- 518
- Latest grant
- 23 Dec 2025
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 6 | 0 |
| 1977 | 5 | 0 |
| 1978 | 1 | 0 |
| 1979 | 10 | 0 |
| 1980 | 2 | 0 |
| 1981 | 5 | 0 |
| 1982 | 1 | 0 |
| 1983 | 3 | 0 |
| 1984 | 2 | 0 |
| 1985 | 8 | 0 |
| 1986 | 6 | 0 |
| 1987 | 10 | 0 |
| 1988 | 2 | 0 |
| 1989 | 6 | 0 |
| 1990 | 7 | 0 |
| 1991 | 5 | 0 |
| 1992 | 7 | 0 |
| 1993 | 6 | 0 |
| 1994 | 7 | 0 |
| 1995 | 10 | 0 |
| 1996 | 4 | 0 |
| 1997 | 5 | 0 |
| 1998 | 8 | 0 |
| 1999 | 6 | 0 |
| 2000 | 7 | 0 |
| 2001 | 8 | 0 |
| 2002 | 6 | 3 |
| 2003 | 1 | 4 |
| 2004 | 2 | 4 |
| 2005 | 3 | 7 |
| 2006 | 2 | 5 |
| 2007 | 1 | 2 |
| 2008 | 4 | 6 |
| 2009 | 3 | 8 |
| 2010 | 3 | 3 |
| 2011 | 4 | 1 |
| 2012 | 0 | 4 |
| 2013 | 5 | 13 |
| 2014 | 7 | 6 |
| 2015 | 5 | 7 |
| 2016 | 2 | 2 |
| 2017 | 9 | 5 |
| 2018 | 4 | 3 |
| 2019 | 5 | 3 |
| 2020 | 2 | 5 |
| 2021 | 4 | 3 |
| 2022 | 1 | 3 |
| 2023 | 2 | 2 |
| 2024 | 1 | 0 |
| 2025 | 3 | 2 |
| 2026 | 0 | 3 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Lanthionine synthetase C-like 2-based therapeutics23 Dec 2025US 12,502,388 B2NImmune Biopharma, Inc.
- Resist composition, method of forming resist pattern, and compound16 Dec 2025US 12,498,635 B2Tokyo Ohka Kogyo.Co., Ltd.
- Compounds having excited state intramolecular proton transfer (ESIPT) character for use in treating and/or preventing sunburn and/or preventing U.V. damage15 Apr 2025US 12,275,711 B2Johannes Gutenberg University
- Compound for modulating DDAH and ADMA levels, as well as methods of using thereof to treat disease2 Jan 2024US 11,858,889 B2The Trustees of Indiana University
- Targeted contrast agents for MRI of alpha-synuclein deposition10 Oct 2023US 11,779,664 B2Alzeca Biosciences, LLC
- Long-chain alkenyloxy-substituted benzoyl derivative and oligonucleotide synthesis method using same17 Sep 2026US 2026/0274885 A1SPERA PHARMA, Inc.
- Lanthionine synthetase c-like 2-based therapeutics19 Mar 2026US 2026/0076962 A1NImmune Biopharma, Inc.
- Polymeric (meth)acrylate photoinitiators12 Mar 2026US 2026/0071077 A1Igm Resins Italia S.R.L.
- Metabotropic glutamate receptor positive allosteric modulators (pams) and uses thereof5 Jun 2025US 2025/0179000 A1Sanford Burnham Prebys Medical Discovery Institute
- Inhibitors of the oncogenic shp2 phosphatase and uses thereof23 Jan 2025US 2025/0026741 A1Sanford Burnham Prebys Medical Discovery Institute
Most cited
By later US patents
- Fluorescent labels for immunoassay105US 4,637,988 AEastman Kodak Company · 1987
- Benzene compound having 2 or more substituents87US 7,923,573 B2Daiichi Sankyo Company, Limited · 2011
- Photodefinable polymers containing perfluorocyclobutane groups80US 5,426,164 AThe Dow Chemical Company · 1995
- Catechol carboxylic acids67US 5,025,036 AHoffmann-La Roche Inc. · 1991
- Chalcone derivatives64US 4,190,671 ABiorex Laboratories Limited · 1980